An Open Banking payment platform that lets merchants take real-time account-to-account payments.
An AI-powered, screen-free audio speaker that helps 4-10 year-olds learn through voice-driven games and stories.
flowMEE automates document accounting, financial data processing and repetitive bookkeeping tasks with AI.
Combines software, automation and professional consultancy to simplify accounting management for Italian SMEs.
Developing a portfolio of small-molecule CLR-pathway inhibitors for innate-immune-driven disorders, starting with Behçet's disease.
An AI-native law firm for commercial legal work, combining AI with qualified-lawyer review and sign-off, billed as a…
Speech-to-Speech Voice AI Model
Shared e-scooters and e-bikes for greener, healthier cities
The Agentic Recruiting Platform
Your AI growth team. You build, we do everything else.
Automating and scaling satellite laser ranging to deliver ultra-precise positioning data on satellites and debris
AI-powered risk intelligence for hybrid threats
Automated transcription you can actually trust
Reimburse every kWh charged at home. Down to the penny.
Building AI world models to simulate extreme physics for applications like fusion reactors and rockets.
Building the leading preventive health platform in Europe, offering a full 360° health check within an hour.
AI platform for the construction industry that turns contractors' unstructured project data into insights and automated workflows.
Designer and manufacturer of surgical training simulators using additive manufacturing and novel software.
Device-as-a-Service platform supplying and managing smartphones, tablets and laptops for businesses.
Vacuum-packed sofa beds designed for easy shipping and quick setup.
A global cellular operator for the Internet of Things, connecting enterprise IoT devices across 180+ countries.
AI-powered robotic guidance that gives industrial robots real-time vision and intelligence on the shop floor.
Clinical-stage biopharmaceutical company developing oral therapies for heart failure, led by its AC01 programme.
Developing oral therapies for vision-threatening retinal diseases such as diabetic retinopathy and age-related macular degeneration.
Is this your startup?
Claim your profile - update details, post jobs, and answer interviews.
Claim your profileSesamers newsletters
Weekly brief every Monday and The Opener twice a month - both included when you subscribe.